Publication Illustrates Need for Therapies to Address Immune Aging in Down Syndrome
Impaired immune function is a clear and growing threat to the health and well-being of people with Down syndrome (DS).
January 12, 2022
Impaired immune function is a clear and growing threat to the health and well-being of people with Down syndrome (DS).
A recent disease prevalence study of the largest documented Down syndrome (DS) cohort in the United States strongly suggested significant
This video is a recording of a webinar about treatments for obstructive sleep apnea presented by Dr. Michael Layland on
In this video, Libby Kumin, Ph.D., CCC-SLP discusses language skills for children in the first grade and into middle school.
Studies suggest human trisomy 21 impacts several diseases in an age-dependent manner. Thus, understanding the possible aging-related mechanisms associated with
Individuals with Down syndrome (DS) have an increased risk for epilepsy during the whole lifespan, but especially after age 40
Given the current life expectancy and number of individuals living with Down syndrome (DS), it is important to learn common
En abril, 2021, la comunidad de Síndrome de Down celebró la publicación de un artículo en el diario: Translational Science
Hidradenitis suppurativa (HS) is associated with comorbidities that contribute to poor health, impaired life quality, and mortality risk.Source: Garg et al.
Pneumonia and respiratory infections impact infants and children with Down syndrome; pneumonia is a leading cause of mortality in adults